Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic profiling of VEXAS syndrome patients

ABSTRACT: Transcriptomic profiling of VEXAS syndrome patients

PROVIDER: PRJNA672843 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12921400_1.fastq.gz	Fastqsanger.gz
	SRR12921400_2.fastq.gz	Fastqsanger.gz
	SRR12921401_1.fastq.gz	Fastqsanger.gz
	SRR12921401_2.fastq.gz	Fastqsanger.gz
	SRR12921402_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 82

Similar Datasets

Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients

Project description:Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients

| PRJNA524936 | ENA

Comparative transcriptomic analysis in patients with Behçet syndrome

Project description:Comparative transcriptomic analysis in patients with Behçet syndrome

| PRJNA861263 | ENA

Transcriptomic and Network Analysis of Minor Salivary Glands of Patients with Sjögren’s Syndrome

Project description:Transcriptomic and Network Analysis of Minor Salivary Glands of Patients with Sjögren’s Syndrome

2021-01-06 | GSE157159 | GEO

Aberrant alternative splicing profiling for myelodysplastic syndrome (MDS) patients

Project description:Transcriptome analysis of total RNA from bone marrow (BM) mononuclear cells of MDS patients and normal dornors Global gene expression and alternative splicing profiling among patients with myelodysplastic syndrome (MDS) compared with normal donors

2018-12-05 | GSE107400 | GEO

Transcriptomic profiling of sporadic Alzheimer’s disease patients

Project description:Transcriptomic profiling of sporadic Alzheimer’s disease patients

| PRJNA839035 | ENA

Transcriptomic analysis of B cells from patients with Sjögren’s Syndrome

Project description:Transcriptomic analysis of B cells from patients with Sjögren’s Syndrome

| PRJNA821859 | ENA

Aberrant alternative splicing profiling for myelodysplastic syndrome (MDS) patients

Project description:Aberrant alternative splicing profiling for myelodysplastic syndrome (MDS) patients

| PRJNA420023 | ENA

Gene expression profiling in myelodysplastic syndrome patients treated with deferasirox

Project description:Gene expression profiling in myelodysplastic syndrome patients treated with deferasirox

| PRJNA674306 | ENA

Immune Profiling of Premalignant Lesions in Patients with Lynch Syndrome

Project description:Immune Profiling of Premalignant Lesions in Patients with Lynch Syndrome

| PRJNA417076 | ENA

Transcriptomic analysis of monocytes, M0, M1 and M2 macropahges from H syndrome patients and SAIDs.

Project description:Biallelic mutations in SLC29A3 cause histiocytosis-lymphadenopathy plus syndrome, also known as H syndrome (HS). HS is a complex disorder, with ~25% of patients developing autoinflammatory complications consisting of unexplained fevers, persistently elevated inflammatory markers and unusual lymphadenopathies, with infiltrating CD68+, S100+ and CD1a– histiocytes, resembling the immunophenotype found in Rosai-Dorfman disease (RDD). We investigated the transcriptomic profiles of monocytes, non-activated (M0), classically-activated (M1) and alternatively-activated macrophages (M2) in two patients with HS, one without autoinflammatory (HS1) and one with autoinflammatory complications (HS2). RNA sequencing revealed a dysregulated transcriptomic profile in both HS patients compared to healthy controls (HC). HS2, when compared to HS1, had several differentially expressed genes, including genes associated with lymphocytic-histiocytic predominance (e.g. NINL) and immunodeficiencies (e.g. B2M). The transcriptomic and cytokine profiles of HS patients were comparable to patients with SAID with high levels of TNF. SERPINA1 gene expression was found to be upregulated in all patients. Moreover, higher levels of IFNg were found in the serum of both HS patients when compared to HC. Gene-ontology (GO) enrichment analysis of the DEGs in HS patients revealed the terms "type I IFN", "IFNg signalling pathway" and "immune responses" as the top 3 most significant terms for monocytes. Finally, the transcriptomic profiles of M0 and M1 macrophages, from patient HS2, were similar to the transcriptomic profile of tissue biopsies taken from patients with RDD-like lymphadenopathies. Monocytes and macrophages from both HS patients showed transcriptomic profiles similar to SAIDs and with a unique dysregulated IFNgsignalling. These findings may help to find better therapeutic options for this rare disorder.

2021-02-16 | GSE155697 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data